Centrum Medyczne ENEL-MED S.A. (WSE:ENE)
Poland
· Delayed Price · Currency is PLN 19.30
-0.60 (-3.02%)
Jun 6, 2025, 10:17 AM CET
Centrum Medyczne ENEL-MED Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 735.59 | 616.77 | 494.9 | 441.14 | 399.8 | Upgrade
|
| Revenue | 735.59 | 616.77 | 494.9 | 441.14 | 399.8 | Upgrade
|
| Revenue Growth (YoY) | 19.27% | 24.62% | 12.19% | 10.34% | -4.28% | Upgrade
|
| Cost of Revenue | 677.09 | 589.43 | 484.02 | 419 | 369.5 | Upgrade
|
| Gross Profit | 58.51 | 27.34 | 10.88 | 22.14 | 30.3 | Upgrade
|
| Selling, General & Admin | 35.54 | 32.9 | 37.12 | 23.82 | 20.23 | Upgrade
|
| Other Operating Expenses | 0.08 | -9.47 | -6.54 | -3.73 | -3.3 | Upgrade
|
| Operating Expenses | 35.62 | 23.44 | 30.58 | 20.09 | 16.93 | Upgrade
|
| Operating Income | 22.89 | 3.9 | -19.7 | 2.06 | 13.37 | Upgrade
|
| Interest Expense | -10.39 | -10.16 | -5.82 | -5.33 | -7.52 | Upgrade
|
| Interest & Investment Income | 1.24 | 1.64 | 2.46 | 1.64 | 1.09 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.12 | 14.61 | -2.83 | 0.61 | -9.98 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.05 | -0.02 | -0.01 | -0.01 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | 14.82 | 9.97 | -25.89 | -1.03 | -3.07 | Upgrade
|
| Merger & Restructuring Charges | 3.55 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.01 | -0.04 | -0.77 | - | -3.24 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.13 | -3.72 | -1.28 | -0.1 | -0.97 | Upgrade
|
| Legal Settlements | -0 | -0.44 | - | -0.02 | -0 | Upgrade
|
| Other Unusual Items | 0.93 | 3.13 | - | 1.24 | 2.8 | Upgrade
|
| Pretax Income | 19.14 | 8.89 | -27.94 | 0.1 | -4.48 | Upgrade
|
| Income Tax Expense | 4.54 | 0.97 | -4.38 | 1.51 | -1.08 | Upgrade
|
| Earnings From Continuing Operations | 14.61 | 7.93 | -23.56 | -1.41 | -3.4 | Upgrade
|
| Net Income | 14.61 | 7.93 | -23.56 | -1.41 | -3.4 | Upgrade
|
| Net Income to Common | 14.61 | 7.93 | -23.56 | -1.41 | -3.4 | Upgrade
|
| Net Income Growth | 84.27% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 28 | 28 | 28 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 28 | 28 | 24 | 24 | Upgrade
|
| Shares Change (YoY) | - | - | 17.55% | 2.08% | - | Upgrade
|
| EPS (Basic) | 0.52 | 0.28 | -0.83 | -0.06 | -0.14 | Upgrade
|
| EPS (Diluted) | 0.52 | 0.28 | -0.83 | -0.06 | -0.14 | Upgrade
|
| EPS Growth | 84.49% | - | - | - | - | Upgrade
|
| Free Cash Flow | 58.34 | 55.17 | -5.9 | 28.55 | 63.44 | Upgrade
|
| Free Cash Flow Per Share | 2.06 | 1.95 | -0.21 | 1.19 | 2.69 | Upgrade
|
| Gross Margin | 7.95% | 4.43% | 2.20% | 5.02% | 7.58% | Upgrade
|
| Operating Margin | 3.11% | 0.63% | -3.98% | 0.47% | 3.34% | Upgrade
|
| Profit Margin | 1.99% | 1.29% | -4.76% | -0.32% | -0.85% | Upgrade
|
| Free Cash Flow Margin | 7.93% | 8.95% | -1.19% | 6.47% | 15.87% | Upgrade
|
| EBITDA | 51.14 | 30.03 | 5.53 | 24.79 | 35.69 | Upgrade
|
| EBITDA Margin | 6.95% | 4.87% | 1.12% | 5.62% | 8.93% | Upgrade
|
| D&A For EBITDA | 28.25 | 26.13 | 25.22 | 22.73 | 22.33 | Upgrade
|
| EBIT | 22.89 | 3.9 | -19.7 | 2.06 | 13.37 | Upgrade
|
| EBIT Margin | 3.11% | 0.63% | -3.98% | 0.47% | 3.34% | Upgrade
|
| Effective Tax Rate | 23.69% | 10.86% | - | 1568.75% | - | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.